Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

BTN2A1/3A1-Fc-CD19scFv

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Shattuck

Drug class:

CD19 inhibitor, γδ TCR modulator

Related drugs:

‹

autologous γδ T lymphocytes (0)

ALEXIS-ISO-1 (0)

NK/γδ T cell-enriched cell therapy (0)

PF-08046052 (0)

anti-CD19-CAR γδT (0)

γδT Cell infusion (0)

γδT Cell infusion agent (0)

blinatumomab (52)

tafasitamab-cxix (3)

CAR-NK-CD19 cells (0)

CB CAR-NK019 (0)

CD19.t-haNK (0)

Imtox19/Imtox22 (0)

inebilizumab-cdon (0)

anti CD19/CD22 CAR NK cells (0)

autologous TRAC locus-inserted CD19-STAR-T (0)

dualCAR-NK19/70 (0)

universal chimeric antigen receptor-modified AT19 cells (0)

Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)

CD7-UCAR-γδT cells (0)

ET1402L1-ARTEMIS T cells (0)

Gamma delta T-cells (0)

autologous γδ T lymphocytes (0)

ALEXIS-ISO-1 (0)

NK/γδ T cell-enriched cell therapy (0)

PF-08046052 (0)

anti-CD19-CAR γδT (0)

γδT Cell infusion (0)

γδT Cell infusion agent (0)

›